
|Slideshows|October 9, 2018
- Managed Healthcare Executive November 2018 Issue
- Volume 28
- Issue 11
Eight Top Oncology Drug Approvals
Author(s)Erin Johanek, PharmD, RPh
New cancer drugs continue to offer patients hope. Here are eight of them.
Advertisement
Articles in this issue
about 7 years ago
Looser Restrictions on HRAs on the Horizonabout 7 years ago
Nine Ways to Deal with Escalating Drug Costsabout 7 years ago
Time to Address ‘Financial Toxicity’ of Cancer Treatmentabout 7 years ago
CAR T-cell Therapy: How Payers are Responding to Huge Price Tagsabout 7 years ago
Medical Foods Strive for Insurance Coverageabout 7 years ago
New Chiefs at MCOs: 4 Positions You May Want to Addover 7 years ago
Eight Predictions for Cancer Care in 10 Yearsover 7 years ago
Is Precision Medicine Worth the Hype? Oncologists Weigh InNewsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FAQ: The uncertain future of enhanced ACA premium subsidies and what it means for U.S. healthcare
2
Weakened brain connections linked to cognitive deficits in schizophrenia
3
Why the great pharma-MedTech divide is healthcare’s biggest miss
4
Don’t let ‘sleepmaxxing’ keep you up at night: Results from the 2025 American Academy of Sleep Medicine survey on sleep tracking
5



























